Twice as likely to survive Colorectal Cancer if had good level of Vitamin D Binding Protein – July 2019

Prediagnostic circulating concentrations of vitamin D binding protein and survival among colorectal cancer patients

Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA DOI: 10.1158/1538-7445.SABCS18-3297
Chen Yuan, Mingyang Song, Brian M. Wolpin, Jeffrey A. Meyerhardt, Shuji Ogino, Bruce W. Hollis, Andrew T. Chan, Charles S. Fuchs, Kana Wu, Molin Wang, Stephanie A. Smith-Warner, Edward L. Giovannucci and Kimmie Ng

VitaminDWiki

Vitamin D Binding Protein category listing has 177 items and the following introduction

Vitamin D Binding Protein (GC) gene can decrease the bio-available Vitamin D that can get to cells,

GC is not the only such gene - there are 3 others, all invisible to standard Vitamin D tests
The bio-available calculation does not notice the effect of GC, CYP27B1, CYP24A1, and VDR
The actual D getting to the cells is a function of measured D and all 4 genes
There is >2X increase in 8+ health problems if have poor VDBP (GC)
It appears that VDBP only blocks oral vitamin D,
- but NOT Vitamin D from sun, UV, topical or inhaled (tissue activated)
- A clue: - Vitamin D from UV is 2X better for MS than oral Vitamin D

VDBP is NOT directly detected by vitamin D blood tests

click on chart for detials

Cancer - Colon category starts with the following

Cancer - Colon category listing has 144 items

see also:
Overview Cancer-Colon and vitamin D. Overview Cancer and vitamin D Overview Gut and vitamin D Cancer and Vitamin D - many studies
Cancer - After diagnosis category listing has 113 items along with related searches
16 factors increase the risk of early-onset colorectal cancer, only vitamin D decreases the risk – meta-analysis May 2023
Colorectal cancer 14 percent less likely if 10 ng more Vitamin D – 22nd meta-analysis – Sept 2022
Colon cancer risk increases 30X if you have the worst vitamin D receptor mutation – Jan 2021

Items in both categories CCR and Vitamin D Binding Protein are listed here:

Higher total 25-hydroxyvitamin D [25(OH)D] levels are associated with an improvement in survival among colorectal cancer (CRC) patients, but the relationships between plasma vitamin D binding protein (VDBP), bioavailable or free 25(OH)D, and CRC survival remain unknown. In two prospective cohort studies, the Health Professionals Follow-Up Study and the Nurses’ Health Study, we examined the association between prediagnostic plasma levels of VDBP, bioavailable 25(OH)D, and free 25(OH)D and survival among 604 participants diagnosed with CRC between 1991 and 2011. Plasma 25(OH)D and VDBP were directly measured, while bioavailable and free 25(OH)D were calculated using a validated formula based on total 25(OH)D, VDBP, and albumin levels. Cox proportional hazards models were used to estimate hazard ratios (HRs) for overall and CRC-specific mortality, adjusted for other prognostic markers and potential confounders.
During the follow-up, there were 279 deaths, 177 of which were due to CRC (63%). Higher VDBP levels were associated with a significant improvement in overall and CRC-specific survival (Ptrend=0.005 and 0.02, respectively).

Compared to patients in the lowest quartile, those in the highest quartile of VDBP had a multivariable-adjusted HR of 0.61 (95% confidence interval CI, 0.42-0.89) for overall mortality and 0.56 (95% CI, 0.35-0.92) for CRC-specific mortality. The results remained similar after further adjustment for total 25(OH)D levels. In contrast, no association with overall or CRC-specific mortality was observed for bioavailable or free 25(OH)D levels. In conclusion, higher prediagnostic plasma VDBP levels were associated with improved survival among CRC patients. The clinical utility of VDBP as a prognostic marker warrants further exploration, as well as research into underlying mechanisms of action.